Sabal Trust CO Merck & Co., Inc. Transaction History

Sabal Trust CO

$1.72 Billion
Q4 2024

A detailed history of Sabal Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sabal Trust CO holds 296,758 shares of MRK stock, worth $25.1 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares

296,758

Previous 381,416 22.2%

Holding current value

$25.1 Million

Previous $43.3 Million 31.84%

% of portfolio

1.72%

Previous 2.37%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$96.31 - $114.76 $8.15 Million - $9.72 Million	-84,658 Reduced 22.2%	296,758 $29.5 Million
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $831,402 - $964,695	-7,480 Reduced 1.92%	381,416 $43.3 Million
Q2 2024 Jul 30, 2024	SELL	$123.8 - $132.96 $1.22 Million - $1.31 Million	-9,862 Reduced 2.47%	388,896 $48.1 Million
Q1 2024 May 03, 2024	SELL	$113.24 - $131.95 $1.01 Million - $1.17 Million	-8,900 Reduced 2.18%	398,758 $52.6 Million
Q4 2023 Jan 24, 2024	SELL	$100.18 - $109.02 $1.63 Million - $1.78 Million	-16,308 Reduced 3.85%	407,658 $44.4 Million
Q3 2023 Oct 10, 2023	SELL	$102.95 - $114.33 $577,549 - $641,391	-5,610 Reduced 1.31%	423,966 $43.6 Million
Q2 2023 Jul 20, 2023	BUY	$108.61 - $118.38 $711,829 - $775,862	6,554 Added 1.55%	429,576 $49.6 Million
Q1 2023 Apr 26, 2023	SELL	$102.94 - $114.86 $1.04 Million - $1.16 Million	-10,077 Reduced 2.33%	423,022 $45 Million
Q4 2022 Jan 31, 2023	SELL	$87.44 - $112.11 $856,824 - $1.1 Million	-9,799 Reduced 2.21%	433,099 $48 Million
Q3 2022 Oct 18, 2022	BUY	$84.53 - $94.96 $133,303 - $149,751	1,577 Added 0.36%	442,898 $38.1 Million
Q2 2022 Jul 18, 2022	BUY	$83.49 - $94.64 $265,748 - $301,239	3,183 Added 0.73%	441,321 $40.2 Million
Q1 2022 Apr 14, 2022	BUY	$73.51 - $82.4 $751,345 - $842,210	10,221 Added 2.39%	438,138 $35.9 Million
Q4 2021 Jan 21, 2022	BUY	$72.28 - $90.54 $1.11 Million - $1.39 Million	15,326 Added 3.71%	427,917 $32.8 Million
Q3 2021 Oct 18, 2021	BUY	$71.68 - $78.83 $1.63 Million - $1.79 Million	22,718 Added 5.83%	412,591 $31 Million
Q2 2021 Jul 16, 2021	BUY	$70.31 - $77.77 $786,768 - $870,246	11,190 Added 2.95%	389,873 $30.3 Million
Q1 2021 Apr 19, 2021	BUY	$68.86 - $81.11 $1.3 Million - $1.53 Million	18,866 Added 5.24%	378,683 $29.2 Million
Q4 2020 Jan 20, 2021	BUY	$71.77 - $79.65 $425,165 - $471,846	5,924 Added 1.67%	359,817 $29.4 Million
Q3 2020 Oct 14, 2020	SELL	$73.18 - $82.95 $733,117 - $830,993	-10,018 Reduced 2.75%	353,893 $29.4 Million
Q2 2020 Jul 13, 2020	SELL	$70.42 - $80.13 $498,362 - $567,080	-7,077 Reduced 1.91%	363,911 $28.1 Million
Q1 2020 Apr 14, 2020	SELL	$63.36 - $87.82 $840,787 - $1.17 Million	-13,270 Reduced 3.45%	370,988 $28.5 Million
Q4 2019 Jan 14, 2020	BUY	$77.58 - $87.54 $229,714 - $259,205	2,961 Added 0.78%	384,258 $34.9 Million
Q3 2019 Oct 15, 2019	BUY	$76.08 - $82.93 $137,476 - $149,854	1,807 Added 0.48%	381,297 $32.1 Million
Q2 2019 Jul 17, 2019	BUY	$69.84 - $81.59 $551,107 - $643,826	7,891 Added 2.12%	379,490 $31.8 Million
Q1 2019 Apr 12, 2019	SELL	$69.58 - $79.36 $851,659 - $971,366	-12,240 Reduced 3.19%	371,599 $30.9 Million
Q4 2018 Feb 01, 2019	SELL	$65.24 - $75.71 $1.37 Million - $1.59 Million	-20,974 Reduced 5.18%	383,839 $29.3 Million
Q3 2018 Oct 16, 2018	BUY	$57.69 - $67.84 $665,569 - $782,670	11,537 Added 2.93%	404,813 $28.7 Million
Q2 2018 Jul 16, 2018	BUY	$50.83 - $59.72 $19.4 Million - $22.7 Million	380,915 Added 3081.59%	393,276 $23.9 Million
Q1 2018 Apr 16, 2018	BUY	$50.96 - $59.23 $234,976 - $273,109	4,611 Added 59.5%	12,361 $674,000
Q4 2017 Feb 07, 2018	BUY	$51.62 - $61.64 $49,142 - $58,681	952 Added 14.0%	7,750 $436,000
Q3 2017 Oct 17, 2017	BUY	$58.67 - $63.13 $398,838 - $429,157	6,798	6,798 $435,000

Others Institutions Holding MRK

# of Institutions

3,914

Shares Held

1.94B

Call Options Held

15.9M

Put Options Held

14M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $214B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabal Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sabal Trust CO with notifications on news.

Account